MedPath
TGA Approval

Biogency B&E (423691)

423691

Biogency B&E

Biogency Pty Ltd

October 3, 2023

Medicine

Medicine

Active

Listed

Active Ingredients

ascorbic acid

copper gluconate

Chrysanthemum sinense

d-alpha-tocopheryl acid succinate

Ginkgo biloba

Lycium chinense

Tagetes erecta

Vaccinium myrtillus

soy phosphatidylserine-enriched soy lecithin powder

zinc citrate dihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Biogency B&E (423691) - TGA 批准文号 | MedPath